Dvl1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DVL1 (Dishevelled Segment Polarity Protein 1) is a key intracellular scaffold protein in the Wnt signaling pathway. DVL1 transduces extracellular Wnt signals from Frizzled receptors to downstream effectors, including β-catenin stabilization. DVL1 localizes to synapses and regulates synaptic formation, function, and plasticity. Mutations in DVL1 cause Robinow syndrome, an autosomal dominant disorder characterized by mesomelic limb shortening, genital hypoplasia, and distinctive facial features. DVL1 dysfunction has been implicated in Alzheimer's disease and autism spectrum disorders.
| Attribute |
Value |
| Protein Name |
Dishevelled Segment Polarity Protein 1 |
| Gene Symbol |
DVL1 |
| Gene ID |
1855 |
| Chromosomal Location |
1p36.33 |
| UniProt ID |
Q92997 |
| PDB ID |
2LAU, 4WTR |
| Molecular Weight |
70 kDa |
| Subcellular Localization |
Cytoplasm, cell membrane, synaptic vesicles |
| Protein Family |
Dishevelled family (DVL1, DVL2, DVL3) |
The DVL1 protein contains several functional domains:
- DIX domain (N-terminal): Mediates homooligomerization and interaction with Axin
- PDZ domain: Binds to Frizzled receptors and other PDZ domain-containing proteins
- DEP domain (C-terminal): Mediates membrane localization and interaction with regulators
Post-translational modifications regulate DVL1 function:
- Phosphorylation: By casein kinase 1 (CK1), PAR-1, and LRP6
- Ubiquitination: Controls protein stability and degradation
- Palmitoylation: Affects membrane association
DVL1 plays critical roles in neural development and function:
- Wnt/β-catenin signaling: Canonical pathway activation for gene transcription
- Planar cell polarity: Non-canonical Wnt signaling for tissue patterning
- Neuronal differentiation: Regulates neural progenitor cell fate
- Synapse formation: Promotes excitatory synapse development
- Synaptic plasticity: Regulates long-term potentiation (LTP) and long-term depression (LTD)
- Dendritic spine morphology: Controls spine density and shape
- Cognitive function: Essential for learning and memory processes
DVL1 interfaces with multiple signaling cascades:
- Wnt/β-catenin pathway
- PCP (planar cell polarity) pathway
- MAPK/ERK pathway
- mTOR signaling
DVL1 dysfunction contributes to AD pathogenesis through multiple mechanisms:
- Amyloid metabolism: DVL1 affects APP processing and Aβ production
- Tau phosphorylation: Wnt signaling regulates tau kinases and phosphatases
- Synaptic dysfunction: Loss of DVL1 function impairs synaptic plasticity
- Neuroinflammation: Cross-talk between Wnt and inflammatory pathways
Research findings (PMID: 24668245) demonstrate altered Wnt signaling in AD brains, with reduced DVL1 expression associated with cognitive decline.
- Dopaminergic neuron function: DVL1 regulates survival of dopaminergic neurons
- α-Synuclein aggregation: Wnt pathway modulation affects aggregation
- Mitochondrial function: Cross-talk between Wnt and mitochondrial quality control
¶ Neurodevelopmental and Psychiatric Disorders
- Autism spectrum disorders: DVL1 mutations linked to ASD
- Intellectual disability: DVL1 haploinsufficiency affects cognitive function
- Schizophrenia: Altered Wnt signaling in disease pathogenesis
Modulating DVL1 and Wnt signaling represents therapeutic strategies:
| Approach |
Agent |
Status |
Notes |
| Wnt pathway activators |
Lithium |
Approved |
Mood stabilizer, enhances Wnt |
| GSK3β inhibitors |
Tideglusib |
Clinical trials |
In development for AD |
| DVL1 modulators |
Various |
Preclinical |
Targeting protein-protein interactions |
| Gene therapy |
AAV-DVL1 |
Research |
Restoring DVL1 expression |
- Blood-brain barrier penetration
- Pathway specificity and off-target effects
- Temporal window for intervention
- UniProt entry - Q92997 - Comprehensive protein information
- PDB structure - 2LAU - DVL1 DIX domain structure
- NCBI Gene - 1855 - Gene reference
- PMID:24668245 - Wnt signaling in Alzheimer's disease
- PMID:25009184 - Developmental pathways in neurodegeneration
The study of Dvl1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:24668245 - Wnt signaling in Alzheimer's disease pathology
- PMID:25009184 - Developmental pathways in neurodegeneration
- PMID:25997342 - DVL proteins in neuronal function
- PMID:26437361 - Sirtuins in neurodegeneration
- PMID:26245252 - Cell signaling in neurodegeneration
- PMID:27292145 - DVL1 mutations in Robinow syndrome
- PMID:28528871 - Wnt signaling in Parkinson's disease
- PMID:30268876 - Synaptic Wnt signaling in AD